(Q33909057)

29 July 2017

1 reference

title

Serotonin autoreceptor function and antidepressant drug action (English)

1 reference

29 July 2017

0 references

S Hjorth

1

1 reference

29 July 2017

H J Bengtsson

2

1 reference

29 July 2017

A Kullberg

3

1 reference

29 July 2017

D Carlzon

4

1 reference

29 July 2017

H Peilot

5

1 reference

29 July 2017

S B Auerbach

6

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 June 2000

1 reference

Journal of Psychopharmacology

29 July 2017

published in

1 reference

29 July 2017

volume

14

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

177-185

1 reference

Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo brain microdialysis study.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The 5-HT1A receptor antagonist (S)-UH-301 augments the increase in extracellular concentrations of 5-HT in the frontal cortex produced by both acute and chronic treatment with citalopram

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

5-HT and antidepressants: new views from microdialysis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

(-)-pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Inhibition of hippocampal 5-HT synthesis by fluoxetine and paroxetine: evidence for the involvement of both 5-HT1A and 5-HT1B/D autoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effectiveness of Pindolol With Selected Antidepressant Drugs in the Treatment of Major Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

5-Hydroxytryptamine release in dorsal hippocampus of freely moving rats: modulation by pindolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Postsynaptic 5-HT1A receptors mediate 5-hydroxytryptamine release in the amygdala through a feedback to the caudal linear raphe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The effect of the selective 5-HT1A agonists alnespirone (S-20499) and 8-OH-DPAT on extracellular 5-hydroxytryptamine in different regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The inhibitory effect of 8-OH-DPAT on the firing activity of dorsal raphe serotoninergic neurons in rats is attenuated by lesion of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Electrophysiological and neurochemical evidence that pindolol has agonist properties at the 5-HT1A autoreceptor in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Electrophysiological evidence for a large receptor reserve for inhibition of dorsal raphe neuronal firing by 5-HT1A agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effects of 5-HT1A receptor antagonists on fluoxetine-induced changes in extracellular serotonin concentrations in rat frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Pindolol increases extracellular 5-HT while inhibiting serotonergic neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Interaction between a selective 5-HT1A receptor antagonist and an SSRI in vivo: effects on 5-HT cell firing and extracellular 5-HT

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effects of (-)-tertatolol, (-)-penbutolol and (+/-)-pindolol in combination with paroxetine on presynaptic 5-HT function: an in vivo microdialysis and electrophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The selective 5-HT1B receptor inverse agonist 1'-methyl-5-[[2'-methyl-4'-(5-methyl-1,2, 4-oxadiazol-3-yl)biphenyl-4-yl]carbonyl]-2,3,6,7-tetrahydro- spiro[furo[2,3-f]indole-3,4'-piperidine] (SB-224289) potently blocks terminal 5-HT autoreceptor func

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Venlafaxine: acute and chronic effects on 5-hydroxytryptamine levels in rat brain in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Lack of 5-HT1A autoreceptor desensitization following chronic citalopram treatment, as determined by in vivo microdialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Autoreceptors remain functional after prolonged treatment with a serotonin reuptake inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

(-)-Pindolol stereospecifically inhibits rat brain serotonin (5-HT) synthesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Is pindolol a mixed agonist-antagonist at central serotonin (5-HT) receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The putative 5-HT1B receptor agonist CP-93,129 suppresses rat hippocampal 5-HT release in vivo: comparison with RU 24969.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Raphe 5-HT1A autoreceptors, but not postsynaptic 5-HT1A receptors or beta-adrenoceptors, restrain the citalopram-induced increase in extracellular 5-hydroxytryptamine in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

WAY100635-induced augmentation of the 5-HT-elevating action of citalopram: relative importance of the dose of the 5-HT1A (auto)receptor blocker versus that of the 5-HT reuptake inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Citalopram's ability to increase the extracellular concentrations of serotonin in the dorsal raphe prevents the drug's effect in the frontal cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Role of 5-HT1A receptors in the effects of acute chronic fluoxetine on extracellular serotonin in the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Dual serotoninergic projections to forebrain in the rat: Morphologically distinct 5-HT axon terminals exhibit differential vulnerability to neurotoxic amphetamine derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

5-HT 1B/D receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Mitchell B. Balter Award--1998. Pindolol and major affective disorders: a three-year follow-up study of 30,485 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Differential effects of 5-HT1B/1D receptor antagonists in dorsal and median raphe innervated brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effect of pindolol on the function of pre- and postsynaptic 5-HT1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

The 5-HT1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Increase in extracellular serotonin produced by uptake inhibitors is enhanced after chronic treatment with fluoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Systemic uptake inhibition decreases serotonin release via somatodendritic autoreceptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

SB-224289--a novel selective (human) 5-HT1B receptor antagonist with negative intrinsic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

GR127935 acts as a partial agonist at recombinant human 5-HT1D alpha and 5-HT1D beta receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

How long should pindolol be associated with paroxetine to improve the antidepressant response?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Inhibition of median and dorsal raphe neurones following administration of the selective serotonin reuptake inhibitor paroxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

Effects of co-administration of a monoamine oxidase inhibitor and a 5-HT1A receptor antagonist on 5-hydroxytryptamine cell firing and release

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F026988110001400208

10.1177/026988110001400208

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference